Delivery Order SPE2DB22D2206-SPE2DB26FDR44
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,669.41 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $2,183.23 to AmerisourceBergen Drug Corp for 100 mg vials of Remicade, a biologic medication commonly used to treat inflammatory conditions. This non-set-aside contract was awarded on April 24, 2025, with an ultimate completion date of April 25, 2025. The delivery order employs firm fixed price terms and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials, with a contract value of $15,706.47 and an ultimate completion date of September 5, 2025. This is a firm fixed price delivery order issued under a competitive procurement with no set-aside designation. The award was made to AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, which serves as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $12,029.28 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. The contract is a firm fixed price delivery order with an ultimate completion date of September 22, 2025, and was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $21,183.76 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. This firm fixed-price contract, awarded on September 4, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for $5,012.20 to supply 100 mg vials of Remicade, a biologic immunosuppressant medication used to treat autoimmune conditions. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 6, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,004.88 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Remicade, a biologic immunosuppressant medication used to treat autoimmune conditions such as rheumatoid arthritis and inflammatory bowel disease. The contract is firm fixed price with an ultimate completion date of September 9, 2025, and represents a competitive, non-set-aside award. The point of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $17,318.52 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and reflects the agency's ongoing pharmaceutical supply needs for military healthcare operations. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Remicade, a biologic medication used primarily to treat inflammatory conditions including rheumatoid arthritis, Crohn's disease, and ulcerative colitis. This firm fixed-price delivery order, valued at $3,093.41, was competitively awarded without set-aside restrictions and carries an ultimate completion date of September 9, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $50,458.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials, with an ultimate completion date of August 21, 2025. This is a non-set-aside competitive award issued on August 20, 2025, with performance to be conducted at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order under its...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDR44Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 100 mg vials of Remicade, a biologic immunosuppressant medication commonly used to treat inflammatory conditions. This firm fixed-price delivery order, valued at $45,100.15, was competitively awarded without set-aside designation and carries an ultimate completion date of October 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this order, which falls under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. This delivery order represents routine pharmaceutical procurement through AmerisourceBergen's established relationship with DLA, which relies on the company as a primary vendor for military and federal healthcare supply needs. The IDC vehicle enables flexible ordering of pharmaceutical products across multiple therapeutic domains to support Defense Health Agency programs and other federal healthcare systems worldwide. AmerisourceBergen's consistent track record of competitively winning federal pharmaceutical contracts demonstrates its capability to fulfill critical medical supply requirements for the federal government's healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.1k | 10/16/25 |